Plain-English translation of NCT06039631 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a treatment strategy for patients with advanced laryngeal (voice box) or hypopharyngeal (lower throat) cancer. After you receive initial treatment with (an immunotherapy drug) combined with chemotherapy, and your cancer shows improvement, you will be randomly assigned to receive either surgery to remove the cancer or concurrent radiation and chemotherapy instead. The goal is to compare how well each approach works and how they affect your quality of life.
Advanced throat cancers are serious, with only about 30โ50% of patients surviving 5 years, even with aggressive treatment. Doctors want to find the best way to treat these cancers while preserving your ability to swallow and speak. This trial compares two different approaches after initial immunotherapy to see which gives the best results with the best quality of life.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
After completing initial immunotherapy and chemotherapy, you will be randomly assigned to one of two groups. In the surgery group, you will undergo an operation to remove the cancer and nearby lymph nodes, possibly followed by additional radiation and chemotherapy based on what the pathology shows, and then follow-up immunotherapy. In the radiation group, you will receive concurrent radiation and chemotherapy treatment. Both groups will have regular clinic visits and imaging scans to monitor your progress and side effects throughout the trial.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
China